TITLE: Peptide Boom in the US: Cryptocurrency Becomes the Primary Payment Method for "Life Drugs" BODY:

The American peptide market is experiencing a true digital renaissance. An analysis of on-chain data for the first quarter of 2026 shows that the volume of cryptocurrency payments for these drugs reached $32 million — almost 8 times more than a year earlier. This is not just a trend, but the formation of a new parallel economy.

image

Dynamics of cryptocurrency payments for peptides.

Peptides, positioned as agents for weight loss, rejuvenation, and muscle gain, have found themselves at the epicenter of a regulatory gray zone. Legal drugs undergo strict clinical trials and are sold in pharmacy chains, but a significant share of online trade goes into the shadows. Cheap analogs from foreign laboratories often do not require a prescription and are labeled as "not for human use" — formally bypassing restrictions.

Why Bitcoin, Not a Credit Card

The key driver of this growth is the refusal of traditional banks and payment systems to service sellers due to high compliance risks. As a result, many suppliers accept only Bitcoin. Notably, for some buyers, this transaction becomes their first experience with cryptocurrencies. For example, a 49-year-old marketer from the US spent $240 on retatrutide from a Chinese supplier, buying Bitcoin for the first time — in the American market, a similar purchase would have cost him $300 monthly.

Three Waves of Growth

The market has gone through three distinct stages. Before 2025, it was a niche "underground" with an inflow of about $200,000 per month. Then the topic came into the spotlight of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the US Department of Health and Human Services. However, the real explosion occurred at the end of 2025, when peptides became mainstream in the TikTok subculture of looksmaxxing, obsessed with improving appearance. The average monthly inflow quadrupled to $9.9 million, and in peak months exceeded $10 million.

Major Players Shift to Stablecoins

The market structure is extremely uneven. The bulk of the volume is concentrated in a narrow group of large sellers. Small players fluctuate between different coins, while professional suppliers work almost exclusively with Bitcoin and stablecoins. For transactions over $1000, "stablecoins" become the standard — this provides protection against volatility in large and cross-border purchases.

The Chinese Connection and Transition from Drug Trafficking

The raw material base is concentrated in China. Over three quarters of 2025, peptide imports from China to the US doubled to $300 million. Notably, some suppliers have moved into this niche from the drug business. For example, the Chinese company Bigreat Technology, which previously supplied precursors for fentanyl and amphetamines to Russia and Kazakhstan, created a separate legal entity for trading cosmetic peptides.

Expert Opinion: The peptide market demonstrates a classic scenario for the development of a "gray" economy on the blockchain. We are observing not just growth, but institutionalization — from small underground schemes to professional suppliers using stablecoins for risk management. This resembles the early days of Silk Road, but with a fundamental difference: the legality of the product remains blurred, and demand is fueled by mass culture and the desire to bypass expensive American pharmaceuticals. If regulators do not intervene, by the end of 2026, this sector could become one of the largest drivers of retail cryptocurrency use in the US.